Model Can Predict Outcome for Immune Checkpoint Inhibitor Treatment
Risk model with six parameters predicts outcome in patients with metastatic cancers of different origins receiving immune checkpoint inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.